Company Filing History:
Years Active: 2018-2021
Title: Guhan Nagappan: Innovator in Neurological Treatments
Introduction
Guhan Nagappan is a notable inventor based in Shanghai, CN. He has made significant contributions to the field of neurological treatments through his innovative research and development. With a total of 2 patents, Nagappan is recognized for his work in creating binding agonists that target specific neurological disorders.
Latest Patents
Nagappan's latest patents focus on TrkB binding agonists for the treatment of neurological and other disorders. The inventions relate to the use of these agonists in addressing various neurological conditions. They also encompass specific TrkB binding agonists that include CDRs, variable regions, heavy and light chains, along with variant sequences thereof.
Career Highlights
Guhan Nagappan is currently associated with GlaxoSmithKline Intellectual Property Development Limited. His work at this esteemed company has allowed him to explore and develop groundbreaking solutions in the medical field. His dedication to innovation has positioned him as a key figure in the realm of neurological research.
Collaborations
Nagappan has collaborated with several talented individuals in his field, including Tejinder Kaur Bhinder and Chong Ding. These partnerships have fostered a collaborative environment that enhances the potential for innovative breakthroughs.
Conclusion
Guhan Nagappan's contributions to the field of neurological treatments through his patents and collaborations highlight his commitment to innovation. His work continues to pave the way for advancements in medical science.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.